SCHEMBL25969797

SCHEMBL25969797

CC(C)(C)OC(=O)N1CCC[C@H]1CCC(C)(O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 1/20 0.45
LMNA P02545 3/20 0.44
KDM1A O60341 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ATM Q13315 2/20 0.43
KLK7 P49862 1/20 0.43
HCRTR2 O43614 1/20 0.42
CYP3A4 P08684 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GMNN O75496 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
RIPK1 Q13546 1/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
UCHL1 P09936 2/20 0.41
GPR119 Q8TDV5 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2689602 0.82 KLK7 (0.49) OPRD1KDM1AMEN1KMT2AKLK7
SCHEMBL13086596 0.82 KLK7 (0.49) OPRD1KDM1AMEN1KMT2AKLK7
SCHEMBL3046705 0.82 KLK7 (0.49) OPRD1KDM1AMEN1KMT2AKLK7
SCHEMBL29174472 0.82 SLC6A1 (0.47) OPRD1LMNAKDM1AMEN1KMT2A
SCHEMBL12067925 0.81 OPRD1 (0.43) OPRD1LMNAKDM1AMEN1KMT2A
SCHEMBL13086758 0.80 MEN1 (0.50) OPRD1MEN1KMT2AKLK7NPC1
SCHEMBL28781922 0.80 OPRD1 (0.46) OPRD1LMNAKDM1AMEN1KMT2A
SCHEMBL698422 0.79 NR1H2 (0.54) OPRD1KDM1AMEN1KMT2AKLK7
SCHEMBL698218 0.79 NR1H2 (0.54) OPRD1KDM1AMEN1KMT2AKLK7
SCHEMBL27854990 0.79 NR1H2 (0.54) OPRD1KDM1AMEN1KMT2AKLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed
US-11718638-B2 Compounds, compositions and methods for synthesis WAVE LIFE SCIENCES LTD. (SG) 2023-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11718638-B2 Compounds, compositions and methods for synthesis ALKBH1, DUT, RNGTT OPRD1 3422/4885LMNA 434/4885KDM1A 3124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.